Novartis profit chilled as mask wearing keeps flu at bay
Drug sales hit as people skip doctor visits during Covid-19 crisis
US states file suit accusing drugs firms of inflating prices by 1,000%
Teva USA says it intends to fight the allegations made in complaint by 44 US states
Novartis touts effectiveness, safety of autoimmune drug copies
Generics unit Sandoz is producing cheaper biosimilar copies in hopes of capturing sales
Novartis names drugs chief as CEO to deliver return to growth
Joe Jimenez to retire in February after eight years at the helm
Biosimilar drugs could save up to €98bn by 2020, says IMS
But savings from lower-cost copies depend on doctor education, healthcare provider strategies
Novartis replaces head of eye care division after profit miss
Company says that fourth-quarter core net income fell 5 per cent to $2.707bn
Mylan may sweeten terms for Perrigo deal
Pharma group chairman told investors he may sweeten the company’s offer for Irish headquartered company by adding terms to reduce the risk to its shareholders
Swiss drug maker Novartis reports first quarter profits
Income for core businesses climbed 9 per cent in the quarter to $3.65 billion
China’s investigation of foreign companies for alleged price fixing extends to pharmaceuticals industry
Inquiry into pricing practices at 60 domestic and foreign drugmakers
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Six Nations 2025
Get the latest news, analysis and match reports from the M6N and W6N championships
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices